Researchers in The Netherlands have tested a fluorescent tracer dye tethered to a cancer drug, which may help surgeons more accurately remove breast tumors and preserve healthy tissue.

The research published in Nature Communications looks at a fluorescent compound called 800C, tethered to bevacizumab (Avastin), a common cancer drug which targets developing blood vessels.